NEW YORK — Translational Development Acquisition Corp. filed detailed financial disclosures on Friday, August 14, 2026, outlining the terms of its newly structured $50 million primary capital investment agreement with solid-state battery manufacturer ProLogium. According to the regulatory filings submitted to the Securities and Exchange Commission, the transaction involves a primary subscription for 5 million Class A shares accompanied by an equivalent number of warrants. The strategic financing initiative is designed to bolster ProLogium's ongoing international commercialization and manufacturing scale-up initiatives.
Corporate financial disclosures indicate that the transaction reinforces ProLogium's capital structure as the company advances its global manufacturing footprint, including its planned GWh-class gigafactory project in Dunkirk, France. ProLogium executives noted that the incoming primary capital will support expanded research and development operations for its proprietary superfluidized all-inorganic solid-state lithium ceramic battery technology. The company reported holding 19,308,802 Class A shares and one Class B share issued and outstanding following the recent corporate adjustments.
Market analysts monitoring the clean energy sector view the transaction as a critical bridge for scaling next-generation battery solutions from advanced pilot lines to high-volume commercial deployment. Institutional investors and participating stakeholders continue to review the definitive merger and transaction documents ahead of upcoming shareholder votes. Final closing procedures for the primary share subscription and associated warrant allocations are slated to proceed following standard regulatory review periods.
Why did Translational Development and ProLogium structure a $50 million share subscription?
Translational Development and ProLogium structured the $50 million primary capital investment to accelerate the global commercial rollout of advanced solid-state battery technologies and support facility development timelines across international manufacturing hubs.
The definitive transaction closing window and related shareholder meeting are scheduled to take place on September 1, 2026.